药石科技(300725.SZ)：拟变更部分募集资金用途暨新增募集资金投资项目

Group 1 - The core point of the article is that the company,药石科技, plans to change the use of funds raised from a previous stock issuance to invest in two new projects instead of the originally planned project [1] - The original project was the "Annual Production of 155 Tons of Innovative Drugs and Key Intermediates CDMO Construction Project" at 浙江晖石药业有限公司 [1] - The new projects include the "Tides (Peptide/Oligonucleotide) New Molecular Drug R&D Service Platform Project" at 南京药石科技股份有限公司 and the "Chemical Synthesis New Molecular Drug Construction Project" at 浙江晖石药业有限公司 [1]